Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy
Contact Info
Unit 266, 267 & 268, Tower B1, Spaze Itech Park Sohna Road Gurugram, Haryana 122018 connect@complinity.com +91 8181 900 600
Follow Us

A Multi-Concept Theme for Digital Agencies and Startups

8181 900 600 Request a Demo Login
logo dark logo light logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Contact Sales
logo dark logo light logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Contact Sales
Mobile Logo
  • Products
    • Compliance Management Software
    • Contract Management Software
    • Secretarial Compliance Software
    • Litigation Management Software
    • Audit Management Software
    • Internal Financial Control Software
    • Enterprise Risk Management Software
  • Pricing
  • Industries
    • Pharmaceutical
    • Hospitality
    • BFSI
    • Manufacturing
    • NBFC
    • Renewable Energy
    • Agriculture
    • ITeS
    • Real Estate
    • Automobile
  • Legal Updates
  • Blogs
  • Videos
  • Downloads
  • Careers
Industry specific-Medical Central Ministry of Health & Family Welfare Drugs and Cosmetics Act, 1940

Alert on falsified versions of Adcetris Injection (Brentuximab Vedotin) manufactured by M/s. Takeda Pharmaceutical Company Ltd.

05-Sep-2023 | No. 42

Central Drugs Standard Control Organization has issued an Alert Notification concerning falsified versions of Adcetris Injection (Brentuximab Vedotin) manufactured by M/s. Takeda Pharmaceutical Company Ltd. According to the notification, the World Health Organization (WHO) has issued a safety alert regarding multiple falsified versions of Adcetris Injection 50mg (Brentuximab Vedotin) manufactured by M/s. Takeda Pharmaceutical Company Ltd. These falsified products have been identified in four different countries, including India. They are primarily available at the patient level and distributed through unregulated supply chains, particularly online. These products have been found in both regulated and illicit supply chains, and sometimes even at the patient level. The WHO has reported the presence of at least 08 different batch numbers of the falsified version in circulation, namely Batch No. 11980412 ED: 04/2024, 12188747 ED: 01/2025, 12188749 ED: 01/2025, 12200242 ED: 01/2025, 12202389 ED: 01/2025, 12203322 ED: 01/2025, 12310404 ED: 09/2025, and 512053 ED: 11/2024. ADCETRIS (Brentuximab Vedotin) is a CD30-directed antibody-drug conjugate indicated for the treatment of patients with Hodgkin lymphoma after the failure of autologous stem cell transplant and systemic anaplastic large cell lymphoma. Based on this information, the following advisory is provided: a) To doctors and Healthcare Professionals: i. Doctors and healthcare professionals should carefully prescribe and educate their patients for reporting any Adverse Drug Reactions (ADRs). b) To consumers and patients: i. Exercise caution and only procure medical products from authorized sources with proper purchase invoices. c) To Regulatory Authorities (All States/UTs Drugs Controllers and all Zonal and Sub-Zonal Offices of CDSCO): i. Instruct your officers to keep strict vigilance on the movement, sale, distribution, and stock of the said drug products in the market.

Upgrade to paid version to access the Notification, Circular & Rules along with the checklist

Get Legal Updates in your email

Request a Demo

Recent Posts in Corporate Laws

Corporate Laws

MCA issues circular regarding Extension of Companies Compliance Facilitation Scheme, 2026 (CCFS-2026) till 15th September 2026

31-Aug-2026 | General Circular No. 04/2026

MCA has issued circular regarding Extension of Companies Compliance Facilitation Scheme, 2026 (CCFS-2026) till 15th September 2026 Through

Read More
Corporate Laws

SEBI issues Extension of timeline for implementation of provisions of SEBI Circular dated June 15, 2026 on norms for base price, price bands, call auction in pre-open session and close-out procedure for Exchange Traded Funds

28-Aug-2026 | HO/47/11/11(1)2026-MRD-POD3/I/19839/2026

SEBI has issued Extension of timeline for implementation of provisions of SEBI Circular dated June 15, 2026 on norms for base price, price b

Read More
Corporate Laws

NSDL reiterate the circular issued by SEBI regarding Acceptance of digitally signed Power of Attorney from FPIs

28-Aug-2026 | NSDL/CIR/II/44/2026

NSDL reiterated the circular issued by SEBI regarding Acceptance of digitally signed Power of Attorney from FPIs Through this circular, Iss

Read More
Corporate Laws

NSDL reiterate the circular issued by SEBI regarding Alignment of SEBI’s Cyber Incident Reporting Portal with FIRE format

28-Aug-2026 | NSDL/CIR/II/45/2026

NSDL reiterated the circular issued by SEBI regarding Alignment of SEBI’s Cyber Incident Reporting Portal with FIRE format Through t

Read More

Recent Posts

Corporate Laws

MCA issues circular regarding Extension of Companies Compliance Facilitation Scheme, 2026 (CCFS-2026) till 15th September 2026

31-Aug-2026 | General Circular No. 04/2026

MCA has issued circular regarding Extension of Companies Compliance Facilitation Scheme, 2026 (CCFS-2026) till 15th September 2026 Through

Read More
Industry Specific-Maritime Laws

Comply with Revised Medical Support Scheme Requirements for Critical/Terminal Illness of Seafarers

28-Aug-2026 | . {6/l {7/2026- I I {lCq!-pill-9l0

This notification revises the implementation procedure for the Medical Support Scheme for Critical/Terminal Illness of the Seafarers’

Read More
Industry Specific-Seeds

Plant Quarantine (Regulation of Import into India) ( Seventh Amendment) Order, 2026

27-Aug-2026 | S.O. 4770(E)

The Central Government has amended the Plant Quarantine (Regulation of Import into India) Order, 2003 by adding specified timber/wood specie

Read More
Industry Specific- Pharma

Addendum to Ceiling Price Fixation of Ringer Lactate Formulations

27-Aug-2026 | S.O. 4776(E)

An official addendum issued by the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, amending previou

Read More
Request a Demo

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy

Complinity Logo Transparent

Complinity is a comprehensive cloud-based Compliance Management Software that helps track and monitor statutory and regulatory compliances.

Quick Links
  • Compliance Software
  • Regulatory Compliance Software
  • Statutory Compliance Software
  • Compliance Tracking Software
  • Legal Updates
Contact Info
Unit 266, 267 & 268, Tower B1
Spaze Itech Park, Sohna Road
Gurugram, Haryana 122018
connect@complinity.com
+91 8181 900 600

Request a Demo

© 2026 Complinity Technologies Private Limited. | Privacy Policy | Data Processing Addendum

Design & Developed By  Infinite IT Solutions

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy
Powered by EssentialPlugin

Request a Demo

By clicking Submit, you acknowledge that you have read and agree with the Privacy Policy

Thank You for your interest in Complinity. Your CV has been forwarded to HR.
In case your profile is shortlisted, HR shall contact you.